Patents Assigned to Retmap, Inc.
  • Patent number: 11766208
    Abstract: The present disclosure provides electroretinography devices configured to detect biopotential signals from an eye of a subject. In some embodiments, the device is configured to prevent the subject's eyelids from closing over the device when placed in contact with the anterior surface of the subject's eye. In some embodiments, the device has a Young's modulus of no more than about 50 MPa. In some embodiments, the device includes a diffusing or refracting element configured to scatter, focus or diverge incident light. In other embodiments, the device includes a void through which incident light can enter the subject's eye without passing through any portion of the device.
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: September 26, 2023
    Assignee: RETMAP, INC.
    Inventors: John R. Hetling, Safa Rahmani, Tamas Ban
  • Patent number: 10952630
    Abstract: The present disclosure provides electroretinography devices configured to detect biopotential signals from an eye of a subject. In some embodiments, the device is configured to prevent the subject's eyelids from closing over the device when placed in contact with the anterior surface of the subject's eye. In some embodiments, the device has a Young's modulus of no more than about 50 MPa. In some embodiments, the device includes a diffusing or refracting element configured to scatter, focus or diverge incident light. In other embodiments, the device includes a void through which incident light can enter the subject's eye without passing through any portion of the device.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: March 23, 2021
    Assignee: Retmap, Inc.
    Inventors: John R. Hetling, Safa Rahmani, Tamas Ban